WST stock: buy or sell?

WST stock price: $150.15 0.98% At close on November 15th, 2019

Updated on:
November 15th, 2019

0

Shares of West Pharmaceutical Services stepped up a tiny 0.98% and closed at $150.15. Friday was the 4th green day in a row, gaining 1.90%.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally.

Should I buy WST stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with West Pharmaceutical Services stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean WST will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is West Pharmaceutical Services stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we collected 2 ratings published for WST stock in the last 30 days.

Is WST a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-7-26Bank of AmericaUnderperformNeutral
2019-5-1Jefferies Financial GroupBuyHold

WST stock analysis

Daily outlook

Shares of West Pharmaceutical Services stepped up a tiny 0.98% and closed at $150.15.

West Pharmaceutical Services ended yesterday at $150.15 and stepped up a tiny 0.98%. Since last Oct/29 when WST stock price broke up the SMA50d line, it gained $7.66 (5.38%). On September, WST hit new all time highs, pushing higher previous ATH of $150.21 recorded on September. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

WST stock chart (daily)

Weekly outlook

Shares of West Pharmaceutical Services stepped up a beatiful 1.64% this week. For 4 weeks in a row, price soared and marked a profit of 6.67%.

WST shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $136.57 late September. Previous top ($151.93) will play as a resistance in possible new gains. Not so far away is the last all-time high West Pharmaceutical Services marked early September. Since SMA20d and SMA40w crossed up late May, WST price climbed $34.13 per share (29.42%). Since price and SMA40w lines crossed up late March, WST climbed $46.86 (45.37%).

WST stock chart (weekly)

WST stock price history

WST IPO was on March 17th, 1980 at $0.00 per share1. Since then, WST stock surged a inf%, with a yearly average of inf%. If you had invested $1,000 in WST stock in 1980, it would worth $inf today.

1: Adjusted price after possible price splits or reverse-splits.

WST stock historical price chart

WST stock reached all-time highs on September with a price of $151.93.

WST stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' WST stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not detected any price prediction for West Pharmaceutical Services stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, West Pharmaceutical Services was in line with the forecasts of the analysts and posted an EPS of $0.73 per share. As soon as we get its posted EPS from the earnings report, we will extend this report.
WST earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.65n/a
2017-Q32017-10-260.530.6726.4%
2017-Q42018-02-150.630.641.6%
2018-Q12018-04-260.640.62-3.1%
2018-Q22018-07-260.650.77.7%
2018-Q32018-10-250.710.767.0%
2018-Q42019-02-140.720.731.4%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, West Pharmaceutical Services annual revenues soared a more than good 7.40% to $1,717.40 M dollars from $1,599.10 marked in 2017. When comparing 2018 vs 2017, in the same way, profit margin (that is, the net income divided by revenues) gained a 2.62% to 12.05%.

WST annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$1,370 M-$112 M8.2%-
2014$1,421 M3.75%$127 M8.9%13.18%
2015$1,400 M-1.52%$96 M6.8%-24.78%
2016$1,509 M7.81%$144 M9.5%50.21%
2017$1,599 M5.96%$151 M9.4%4.94%
2018$1,717 M7.40%$207 M12.0%37.29%

Quarterly financial results

West Pharmaceutical Services reported $422.50 M in revenues for 2018-Q4, a -2.13% less compared to previous quarter. Reported quarter income marked $52.00 million with a profit margin of 12.31%. Profit margin remained steady a -0.48% compared to previous quarter when profit margin was 12.79%. When comparing turnover to same quarter last year, West Pharmaceutical Services sales marked a slightly good growth and grew a 1.66%. Looking back to recent quarterly results, West Pharmaceutical Services posted 2 negative quarters in a row.
WST quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$398 M-$39 M9.8%-
2017-Q3$399 M0.23%$51 M12.8%31.44%
2017-Q4$416 M4.24%$0 M0.0%-100.00%
2018-Q1$416 M0.02%$44 M10.5%0.00%
2018-Q2$448 M7.65%$56 M12.5%28.67%
2018-Q3$432 M-3.53%$55 M12.8%-1.60%
2018-Q4$423 M-2.13%$52 M12.3%-5.80%
2019-Q1$444 M4.97%$55 M12.5%6.54%

West Pharmaceutical Services ownership

When you are planning to buy shares of a company, it's always worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For West Pharmaceutical Services, 0.96% of all outstanding shares are owned by its staff.

Bearish positions for WST stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to West Pharmaceutical Services:

WSTATRSBAXBDXICUI
Market cap$11.1 B$679.0 M$41.6 B$67.0 B$3.6 B
Total shares74.0 M163.2 M510.6 M270.0 M20.7 M
Float shares73.3 M150.6 M509.7 M269.9 M19.2 M
  - Institutional holdings (%)95.2%42.3%88.2%87.5%93.5%
  - Insider holdings (%)1.0%7.3%0.1%0.3%7.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

WST summary

Friday, November 15th, 2019
Open$149.12
Close$150.15
Day range$148.78 - $150.59
Previous close$148.69
Session gain0.98%
Average true range$2.19
50d mov avg$143.08
100d mov avg$139.11
200d mov avg$125.70
Daily pattern
Weekly pattern lb03a

West Pharmaceutical Services performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For West Pharmaceutical Services, the comparison is made against Antares Pharma, Baxter International, Becton, Dickinson and, ICU Medical, , Medtronic, Stryker and Teleflex.
Stock3m6m12m
WSTWest Pharmaceutic...3.63%29.28%37.02%
ATRSAntares Pharma32.48%48.04%23.08%
BAXBaxter Internatio...-6.12%7.77%23.77%
BDXBecton, Dickinson...0.29%9.41%2.18%
ICUIICU Medical5.09%-22.33%-28.06%
JNJ3.50%-1.24%-5.02%
MDTMedtronic9.60%29.09%22.22%
SYKStryker-4.73%12.56%21.12%
TFXTeleflex-6.10%17.42%32.88%

West Pharmaceutical Services competitors

We picked a few stocks to conform a list of West Pharmaceutical Services competitors to review if you are interested in investing in WST: